UnknownPhase 2NCT02192229

Efficacy of the Dose Regimen of Oral Vitamin D 50,000 IU in the Treatment of Vitamin D Deficiency

Studying Disorders of vitamin D metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hayat Pharmaceutical Co. PLC
Principal Investigator
Talal Aburjai, Ph.D.
University of Jordan
Intervention
50.000 IU vitamin D3 (Biodal 50,000 IU)(drug)
Enrollment
80 target
Eligibility
18-49 years · All sexes
Timeline
20142014

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02192229 on ClinicalTrials.gov

Other trials for Disorders of vitamin D metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorders of vitamin D metabolism

← Back to all trials